BRISBANE'S WORLD-FIRST ASTHMA TREATMENT

BRISBANE'S WORLD-FIRST ASTHMA TREATMENT
ASTHMA sufferers: Brisbane drug development company Invion (ASX: IVX) has partnered with a global manufacturer to progress development of a novel asthma treatment.

The inhaled INV104 has been coined as a potential new treatment for asthma, which is estimated to afflict 300 million people worldwide.

The global market for asthma therapeutics is more than $22 billion per annum.

The compound already exists but is now being reformulated for inhalation. Hovione Scienta has collaborated with Invion to develop the proprietary novel technology, which is a dry powder formulation of the compound delivered by an inhaler.

Hovione will provide expertise on chemistry, particle engineering, formulation, device and GMP manufacturing, while IVX will oversee all non-clinical and clinical development, and remain responsible for regulatory submissions.

This trajectory for growth comes as IVX has received agreement from the FDA to proceed in accelerated development of the new formulation and device.

IVX CEO and managing director Greg Collier says, both medically and commercially, the new method is superior.

"We are reformulating this compound for inhalation and remain confident that delivering this compound directly into the lung in this manner will provide superior benefit and bypass any problems associated with systemic delivery," says Collier.

"Hovione is the right partner to help us capitalise on this highly promising commercial opportunity."


Help us deliver quality journalism to you.
As a free and independent news site providing daily updates
during a period of unprecedented challenges for businesses everywhere
we call on your support

How communications technology can raise the bar on customer service, employee experience
Partner Content
From capturing feedback early to providing messages with a higher rate of cut-through, ...
Advertisement

Related Stories

Hard seltzer start-up enters non-alcoholic market with launch of Fellr Free

Hard seltzer start-up enters non-alcoholic market with launch of Fellr Free

Alcoholic pre-mix brand Fellr is expanding its core range of produc...

The co-founder question: Do you need one, and how do you find someone?

The co-founder question: Do you need one, and how do you find someone?

I’ve played beach volleyball for Australia for the last decad...

EML Payments awarded $320m government contract to help stimulate the Spanish arts sector

EML Payments awarded $320m government contract to help stimulate the Spanish arts sector

Global payment solutions business EML Payments (ASX: EML) will play...

Microbio goes public as med-tech tackles condition that causes 11 million deaths per year

Microbio goes public as med-tech tackles condition that causes 11 million deaths per year

Brisbane-based medical technology company Microbio has stepped...